Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

539 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
Wong G, Brinkman A, Benefield RJ, Carlier M, De Waele JJ, El Helali N, Frey O, Harbarth S, Huttner A, McWhinney B, Misset B, Pea F, Preisenberger J, Roberts MS, Robertson TA, Roehr A, Sime FB, Taccone FS, Ungerer JP, Lipman J, Roberts JA. Wong G, et al. Among authors: harbarth s. J Antimicrob Chemother. 2014 May;69(5):1416-23. doi: 10.1093/jac/dkt523. Epub 2014 Jan 16. J Antimicrob Chemother. 2014. PMID: 24443514
Guidelines for vancomycin use.
Huttner A, Harbarth S. Huttner A, et al. Among authors: harbarth s. Clin Infect Dis. 2010 Feb 15;50(4):616. doi: 10.1086/650175. Clin Infect Dis. 2010. PMID: 20095836 No abstract available.
Beads vs bugs?
Huttner AC, Harbarth S. Huttner AC, et al. Among authors: harbarth s. Chest. 2012 May;141(5):1136-1137. doi: 10.1378/chest.11-2637. Chest. 2012. PMID: 22553258 No abstract available.
Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study.
Huttner A, Von Dach E, Renzoni A, Huttner BD, Affaticati M, Pagani L, Daali Y, Pugin J, Karmime A, Fathi M, Lew D, Harbarth S. Huttner A, et al. Among authors: harbarth s. Int J Antimicrob Agents. 2015 Apr;45(4):385-92. doi: 10.1016/j.ijantimicag.2014.12.017. Epub 2015 Jan 19. Int J Antimicrob Agents. 2015. PMID: 25656151
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
Kostyanev T, Bonten MJ, O'Brien S, Steel H, Ross S, François B, Tacconelli E, Winterhalter M, Stavenger RA, Karlén A, Harbarth S, Hackett J, Jafri HS, Vuong C, MacGowan A, Witschi A, Angyalosi G, Elborn JS, deWinter R, Goossens H. Kostyanev T, et al. Among authors: harbarth s. J Antimicrob Chemother. 2016 Feb;71(2):290-5. doi: 10.1093/jac/dkv339. Epub 2015 Nov 15. J Antimicrob Chemother. 2016. PMID: 26568581 Review.
The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial.
van Duijn PJ, Verbrugghe W, Jorens PG, Spöhr F, Schedler D, Deja M, Rothbart A, Annane D, Lawrence C, Nguyen Van JC, Misset B, Jereb M, Seme K, Šifrer F, Tomiç V, Estevez F, Carneiro J, Harbarth S, Eijkemans MJC, Bonten M; SATURN consortium. van Duijn PJ, et al. Among authors: harbarth s. Lancet Infect Dis. 2018 Apr;18(4):401-409. doi: 10.1016/S1473-3099(18)30056-2. Epub 2018 Jan 26. Lancet Infect Dis. 2018. PMID: 29396000 Clinical Trial.
539 results